Across Europe, scalp cooling is a routine part of cancer care. In many hospitals, it’s not a luxury; it’s offered as a standard part of the treatment plan. Patients have options: machine-based systems in clinics, or flexible, portable caps they can self-manage, whether during treatment in hospital or afterwards at home.
In Australia, however, access is far more uneven. Many patients are never even told scalp cooling exists. This raises an important question:
Why is a proven, widely accepted treatment option still so rare here?
The Promise of Scalp Cooling
Scalp cooling works by reducing blood flow to the hair follicles during chemotherapy, which can minimise hair loss. For many patients, this isn’t just about appearance — it’s about dignity, identity, and a sense of control during a challenging time.
In Europe, Arctic Heat chemo caps have been part of that solution for years. Hospitals use them daily, and patients can purchase their own for at-home use. The result? More people get access, faster.
Australia’s Uneven Access
A 2024 study from Supportive Care in Cancer highlighted that scalp cooling was introduced in Australia only relatively recently, despite decades of use in Europe.
Barriers to uptake include:
- Increased nursing workload
- Disruption to clinic workflows
- Lack of organisational support for implementation
Further, Australia’s oncology systems generally don’t receive Medicare funding for scalp cooling, meaning availability often depends on individual hospital budgets or donor support.Â
Is It Awareness, Access, or Attitude?
Why the gap? Possible reasons include:
- Limited equipment — Machine-based cooling systems are costly and require dedicated clinic space.
- Lack of awareness — Some healthcare professionals are unfamiliar with portable, proven alternatives.
- Perceived priorities — In an overstretched system, supportive treatments can be deprioritised.
Whatever the reason, the result is the same: Australians are missing out on a treatment that’s standard elsewhere.
A Simpler Solution Exists
Portable chemo caps, like those from Arctic Heat, make scalp cooling more accessible. They:
- Don’t require hospital machines
- Can be self-managed by patients in hospital or between treatment sessions at home
- Are already trusted by hospitals across Europe
They are an alternative for machine systems, they give patients another choice. And choice matters.
Why This Conversation Matters
Scalp cooling is a proven method that helps patients retain hair and dignity during chemotherapy. Yet in Australia, its availability is still patchy — not because it doesn’t work, but because of infrastructure, funding, and workflow challenges and professional awareness.
If scalp cooling is standard care across Europe, why not here?
Every patient deserves the right to know their options and make an informed choice.
Learn more about Arctic Heat chemo caps.
